A physician survey finds a gap between guidelines and real-world clinical practice in treatment intensification for ...

The implementation of an auto-recruit system effectively increased rates of bone health screening in patients with prostate cancer undergoing androgen deprivation therapy (ADT), according to a study ...

Opens in a new tab or window or on the link below. Androgen-deprivation therapy (ADT) is well established as the standard of care in metastatic prostate cancer (PCa) management; however ...

More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation therapy, according to researchers.

Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. Although ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...

Study Rundown: Androgen-deprivation therapy (ADT) combined with docetaxel and abiraterone has been shown to improve survival ...

This page includes links to articles highlighting the top genitourinary cancer research published on Cancer Therapy Advisor in 2024.

Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...

Data from the phase 3 CAPItello-281 trial showed that capivasertib plus abiraterone and androgen deprivation therapy significantly improved radiographic progression-free survival in patients with PTEN ...

A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new ...